Baseline

After 8 weeks of ingestion

Standard value

TSE

Placebo

TSE

Placebo

Total protein (g/dL)

7.2 ± 0.3

7.3 ± 0.4

7.0 ± 0.4

7.3 ± 0.4*

6.7 - 8.3

Total bilirubin (mg/dL)

0.96 ± 0.55

0.80 ± 0.25

0.88 ± 0.31

0.86 ± 0.32

0.2 - 1.2

Urea N (mg/dL)

12.7 ± 3.1

12.6 ± 3.1

12.4 ± 3.0

13.0 ± 2.8

8 - 20

Creatinine (mg/dL)

0.61 ± 0.07

0.62 ± 0.08

0.59 ± 0.08

0.61 ± 0.08

0.47 - 0.79

Uric acid (mg/dL)

4.1 ± 1.0

4.2 ± 0.9

3.9 ± 1.0

4.2 ± 1.0

2.5 - 7.0

Total cholesterol (mg/dL)

235 ± 27

228 ± 34

239 ± 24

238 ± 35

120 - 219

LDL cholesterol (mg/dL)

141 ± 25

133 ± 33

145 ± 24

140 ± 34

65 - 139

HDL cholesterol (mg/dL)

75 ± 15

80 ± 21

78 ± 15

83 ± 21

40 - 95

Triglyceride (mg/dL)

109 ± 81

78 ± 30

86 ± 41

78 ± 34

30 - 149

HbA1c (%)

5.3 ± 0.3

5.4 ± 0.3

5.3 ± 0.3

5.4 ± 0.3

4.6 - 6.2

Glycoalbumin (%)

14.2 ± 1.4

14.2 ± 1.6

13.7 ± 1.5

13.7 ± 1.3

12.3 - 16.5

Blood glucose (mg/dL)

85 ± 10

84 ± 6

88 ± 15

83 ± 8

70 - 109

Amylase (U/L)

88 ± 25

86 ± 31

91 ± 30

85 ± 24

40 - 122

CK (U/L)

96 ± 52

108 ± 53

88 ± 45

116 ± 50

40 - 150

AST (U/L)

20.7 ± 7.8

21.3 ± 4.5

20.6 ± 6.5

21.8 ± 5.7

10 - 40

ALT (U/L)

16.5 ± 10.0

17.0 ± 9.7

16.7 ± 8.8

17.1 ± 10.1

5 - 45

γ-GTP (U/L)

15.6 ± 4.0

17.0 ± 7.2

15.6 ± 4.3

17.7 ± 7.9

<30

ALP (U/L)

173 ± 56

201 ± 61

165 ± 52

201 ± 65

100 - 325

LAP (U/L)

47 ± 7

49 ± 6

46 ± 6

50 ± 5

37 - 61

LDH (U/L)

187 ± 32

191 ± 23

183 ± 31

197 ± 24

120 - 240

Na (mEq/L)

140 ± 2

140 ± 2

141 ± 2

140 ± 1

137 - 147

K (mEq/L)

4.1 ± 0.3

4.2 ± 0.3

4.2 ± 0.2

4.2 ± 0.3

3.5 - 5.0

Cl (mEq/L)

100 ± 2

100 ± 2

101 ± 2

101 ± 1

98 - 108

Ca (mg/dL)

9.1 ± 0.4

9.3 ± 0.3

9.3 ± 0.3

9.4 ± 0.3

8.4 - 10.4

Fe (µg/dL)

102 ± 28

103 ± 25

90 ± 33

102 ± 33

40 - 180

Inorganic P (mg/dL)

3.8 ± 0.5

3.5 ± 0.5

3.7 ± 0.3

3.4 ± 0.4

2.5 - 4.5